Bartox Consulting Ltd

Study design including amendments to standard (ICH/OECD/EPA guideline) designs based on expected pharmacological/class-based considerations or to follow up previous equivocal findingsSelection of suitable laboratories for study placement • Study monitoring to ensure compliance with GLP and early availability of interim findings and allowing adaption of pre-clinical programme if findings so require • Data review and interpretation, including a detailed understanding of procedures, and their inherent limitations, permitting expert insight into the validity, strength and accuracy of the conclusions • Report writing or peer review • Integration of data from 2 or more sources to give overall conclusion • Assistance with REACH dataset summaries